CAR-T Therapy Complicated by Cavitary CMV

被引：0

作者：

Menon, D. Padmanabhan ^{[1
]}

Debella, Y. T. ^{[2
]}

Marin-Acevedo, J. A. ^{[1
]}

Fernandez-Bussy, S. ^{[3
]}

Mira-Avendano, I. C. ^{[4
]}

机构：

[1] Mayo Clin, Internal Med, Jacksonville, FL 32224 USA

[2] Mayo Clin, Jacksonville, FL 32224 USA

[3] Mayo Clin, Pulm & Crit Care, Ponte Vedra Beach, FL USA

[4] Mayo Clin, Ponte Vedra, FL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

A5202

引用

页数：2

共 50 条

[1] CAR-T Cell Therapy
Ahmad, Aamir
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12)
[2] CONTROLLING CAR-T THERAPY
Cross, Ryan
[J]. CHEMICAL & ENGINEERING NEWS, 2018, 96 (19) : 32 - 37
[3] CAR-T cell therapy
San Segundo, Lucrecia Yanez
[J]. MEDICINA CLINICA, 2021, 156 (03): : 123 - 125
[4] Biomarkers for CAR-T Cell Therapy
不详
[J]. TRANSFUSIONSMEDIZIN, 2024, 14 (03) : 123 - 124
[5] CAR-T Cell Therapy and Beyond
Dotti, Gianpietro
[J]. PEDIATRIC BLOOD & CANCER, 2017, 64 : S4 - S4
[6] Target selection for CAR-T therapy
Wei, Jianshu
Han, Xiao
Bo, Jian
Han, Weidong
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (1)
[7] CAR-T Cell Therapy for Lymphoma
Ramos, Carlos A.
Heslop, Helen E.
Brenner, Malcolm K.
[J]. ANNUAL REVIEW OF MEDICINE, VOL 67, 2016, 67 : 165 - 183
[8] Building safety into CAR-T therapy
Peters, Daniel T.
Savoldo, Barbara
Grover, Natalie S.
[J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (03)
[9] CAR-T Cell Therapy and the Neurointensivist
Wijdicks, Eelco F. M.
Rabinstein, Alejandro A.
Lin, Yi
[J]. NEUROCRITICAL CARE, 2024, : 691 - 694
[10] Relapses After CAR-T Therapy
Abbasi, Jennifer
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (18): : 1850 - 1850